Suptavumab Biosimilar - Research Grade

Human

RSVï؟½

5mg/ml

IgG1 - kappa

CHO Cells

https://www.imgt.org/mAb-DB/

ICH3002

Blue ice

The respiratory syncytial virus (RSV) fusion machinery mediates viral entry and is a leading antigen for antiviral neutralization research. Described here is a non-therapeutic, unconjugated analog of suptavumab, a recombinant anti-RSV monoclonal antibody for research use only. It is manufactured to in vivo standards with low endotoxin and supplied in scalable milligram to gram quantities for bulk and high-throughput laboratories. Applications include viral neutralization functional assays, in vitro fusion-protein binding screens, and in vivo RSV challenge models. Its purity and dependable supply support reproducible work in demanding, high-throughput settings. Consistent quality across lots makes it a practical choice for laboratories running sustained study programs.

This monoclonal antibody was purified using Protein A

Sterile, preservative-free, solution in PBS. BSA and Azide free.

This biosimilar is stable when stored at 2-8°C. For longer term storage (> 3 months) it is recommended to store this antibody at -20°C or -70°C.

Functional Assays

This biosimilar is for research use only (RUO): it is not for diagnostic or therapeutic procedures and cannot be purchased by patients.

Products are for research use only. Not for use in diagnostic or therapeutic procedures.

3-4 weeks